A palatinose-based balanced formula improves glucose tolerance, serum free fatty acid levels and body fat composition

被引:23
作者
Oizumi, Toshihide
Daimon, Makoto
Jimbu, Yumi
Kameda, Wataru
Arawaka, Nobuko
Yamaguchi, Hiroshi
Ohnuma, Hiroshi
Sasaki, Hajime
Kato, Takeo
机构
[1] Yamagata Univ, Sch Med, DNHMED, Yamagata 9909585, Japan
[2] Meiji Dairies Corp, Inst Food Sci, Odawara, Japan
关键词
palatinose; free fatty acid; visceral fat area; glucose tolerance; metabolic syndrome;
D O I
10.1620/tjem.212.91
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Palatinose is a disaccharide present in honey, which has the characteristics of delayed digestion and absorption. We developed a palatinose-based balanced formula (PBF) and reported its beneficial effects on metabolic syndromerelated parameters in rats. To examine the effects of PBF in humans, we here conducted a crossover study using twenty-three subjects with impaired glucose tolerance. The subjects were divided into two groups: intervention to control (I/C) and control to intervention (C/I) groups. The I/C group consumed PBF (250 kcal) together with foods that were 250 kcal less than their usual breakfast (intervention meal) for the first 12 weeks, followed by their usual breakfast (control meal) for the last 12 weeks. The protocol for the C/I group was opposite in order: the control meal for the first 12 weeks, followed by the intervention meal for the last 12 weeks. In the first 12-week period, the intervention meal decreased 2-hr plasma glucose levels after 75-9 oral glucose tolerance test (-15.7 +/- 20.1 % change), while the control meal did not (0.8 +/- 31.6% change). The difference between these changes was significant (p = 0.038). The similar results were obtained from the comparison of the changes between the first and the last 12-week periods in the two groups combined (intervention vs control: -11.8 +/- 22.5 vs 11.2 +/- 30.2% change, p = 0.024). PBF also had the beneficial effects on serum free fatty acids levels and visceral fat area. In conclusion, PBF consumption has beneficial effects on metabolic syndrome-related parameters in humans.
引用
收藏
页码:91 / 99
页数:9
相关论文
共 29 条
[1]   Effect of a novel palatinose-based liquid balanced formula (MHN-01) on glucose and lipid metabolism in male Sprague-Dawley rats after short- and long-term ingestion [J].
Arai, H ;
Mizuno, A ;
Matsuo, K ;
Fukaya, M ;
Sasaki, H ;
Arima, H ;
Matsuura, M ;
Taketani, Y ;
Doi, T ;
Takeda, E .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2004, 53 (08) :977-983
[2]   Effects of a palatinose-based liquid diet (Inslow) on glycemic control and the second-meal effect in healthy men [J].
Arai, Hidekazu ;
Mizuno, Akira ;
Sakuma, Masae ;
Fukaya, Makiko ;
Matsuo, Kaoru ;
Muto, Kazusa ;
Sasaki, Hajime ;
Matsuura, Motoi ;
Okumura, Hisami ;
Yamamoto, Hironori ;
Taketani, Yutaka ;
Doi, Toshio ;
Takeda, Eiji .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2007, 56 (01) :115-121
[3]  
Bretzel RG, 1998, EXP CLIN ENDOCR DIAB, V106, P369
[4]   PHYSIOLOGICAL IMPORTANCE OF DEFICIENCY IN EARLY PRANDIAL INSULIN-SECRETION IN NON-INSULIN-DEPENDENT DIABETES [J].
BRUCE, DG ;
CHISHOLM, DJ ;
STORLIEN, LH ;
KRAEGEN, EW .
DIABETES, 1988, 37 (06) :736-744
[5]   Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial [J].
Chiasson, JL ;
Josse, RG ;
Gomis, R ;
Hanefeld, M ;
Karasik, A ;
Laakso, M .
LANCET, 2002, 359 (9323) :2072-2077
[6]   HUMAN INTESTINAL DISACCHARIDASES AND HEREDITARY DISACCHARIDE INTOLERANCE - HYDROLYSIS OF SUROSE, ISOMALTOSE, PALATINOSE (ISOMALTU-MALTO-OLIGOSACCHARIDE) PREPARATION [J].
DAHLQVIST, A ;
AURICCHIO, S ;
PRADER, A ;
SEMENZA, G .
JOURNAL OF CLINICAL INVESTIGATION, 1963, 42 (04) :556-&
[7]   No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malmo Preventive Trial with diet and exercise [J].
Eriksson, KF ;
Lindgärde, F .
DIABETOLOGIA, 1998, 41 (09) :1010-1016
[8]   Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies [J].
Hanefeld, M ;
Cagatay, M ;
Petrowitsch, T ;
Neuser, D ;
Petzinna, D ;
Rupp, M .
EUROPEAN HEART JOURNAL, 2004, 25 (01) :10-16
[9]  
Herman WH, 2003, DIABETES CARE, V26, P36
[10]   Evaluation of the novel Tanita body-fat analyser to measure body composition by comparison with a four-compartment model [J].
Jebb, SA ;
Cole, TJ ;
Doman, D ;
Murgatroyd, PR ;
Prentice, AM .
BRITISH JOURNAL OF NUTRITION, 2000, 83 (02) :115-122